Content area

Abstract

Increasing attention is being focused on skin health currently, especially the excessive deposition of melanin in the skin. Tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is a crucial enzyme in melanin synthesis. However, existing tyrosinase inhibitors pose some degree of toxicity to humans. Therefore, the development of more efficient and low-toxicity tyrosinase inhibitors is urgently needed. This review briefly depicts the melanin biosynthesis process and the crystal structure and catalytic mechanism of tyrosinase. The latest research progress regarding small-molecule tyrosinase inhibitors is also reviewed. Moreover, the structure–function relationships are analyzed and summarized. This is expected to provide new and more scientific insights to enable researchers to explore safer and more potent tyrosinase inhibitors.

Details

1009240
Title
Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation
Author
Ni, Xinhua 1 ; Luo, Xinyu 1 ; Jiang, Xiaoying 1 ; Chen, Wenchao 1 ; Bai, Renren 1   VIAFID ORCID Logo 

 School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China; Key Laboratory of Elemene Class Anti-Tumor Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou 311121, China 
Publication title
Molecules; Basel
Volume
30
Issue
4
First page
788
Publication year
2025
Publication date
2025
Publisher
MDPI AG
Place of publication
Basel
Country of publication
Switzerland
Publication subject
e-ISSN
14203049
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-02-08
Milestone dates
2025-01-02 (Received); 2025-02-07 (Accepted)
Publication history
 
 
   First posting date
08 Feb 2025
ProQuest document ID
3171127841
Document URL
https://www.proquest.com/scholarly-journals/small-molecule-tyrosinase-inhibitors-treatment/docview/3171127841/se-2?accountid=208611
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-07-24
Database
ProQuest One Academic